Bio-Techne (TECH) operating income was $252M in FY2026 (+146% YoY). The tables below show the complete quarterly and annual operating income history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Income
Fiscal Year
Operating Income
YoY
2026
$252M
+146%
2025
$102M
-53%
2024
$219M
-28%
2023
$303M
+2%
2022
$298M
+26%
2021
$237M
+51%
2020
$158M
+7%
2019
$147M
+7%
2018
$137M
+13%
2017
$121M
-20%
2016
$151M
+2%
2015
$147M
-8%
2014
$160M
+100708%
2013
$158,469
-100%
2012
$166M
+2%
2011
$163M
+4%
2010
$156M
+4%
2009
$151M
Recent Quarterly Operating Income
Quarter
Operating Income
Q2 2026
$74M
Q1 2026
$75M
Q4 2025
$54M
Q3 2025
$48M
Q2 2025
-$24M
Q1 2025
$39M
Q4 2024
$47M
Q3 2024
$40M
Q2 2024
$67M
Q1 2024
$68M
Q4 2023
$49M
Q3 2023
$56M
Source: TECH on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.